Automating Cell Therapy Manufacturing Without Redesigning Established Workflows

As cell therapy programs move toward the clinic, manufacturing teams are challenged to balance automation with the need to protect established processes. Concerns around workflow disruption, reduced flexibility, and potential delays often slow adoption. A more practical path is emerging—one that allows teams to introduce automation without redesigning what already works. By enabling closed, automated processing that aligns with existing media, reagents, and process logic, newer platform approaches support stepwise implementation. Real-world development examples highlight how teams can map current workflows, minimize operational risk, and maintain control over critical process knowledge.

Learn about how incremental automation strategies can help move programs forward without compromise.